91
Growth Score
pts
Heat Score
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
705647
REFXN Bio develops biotechnology therapies to restore frataxin protein function for Friedreich's ataxia.
About the Company
REFXN Bio develops biotechnology therapies that target the underlying protein deficiency in Friedreich's ataxia. The company focuses on restoring expression and function of the mitochondrial protein frataxin to address the root cause of the disease. Its research and development activities center on genetic and molecular approaches designed to
re-establish functional mitochondrial pathways. REFXN Bio advances a pipeline of pre-clinical therapeutic candidates aimed at safely increasing frataxin levels in affected tissues. The organization concentrates on translating target identification and molecular restoration strategies into scalable interventions for patients with this inherited neurodegenerative disorder.
